Skip to main content


  • AddRemove
  • Build a Report 
Media Coverage

Plaintiffs Lose Attempt to Revive Claims Against Generic, Branded Drug Makers

3 December 2013
Bloomberg BNA Product Safety & Liability Reporter (subscription required)
Litigation & Dispute Resolution partner Hank Bullock (New York) is mentioned as representing Schwarz Pharma Inc. and Alaven Pharmaceuticals LLC in an article reporting that the US Circuit Court of Appeals for the Sixth Circuit refused to revive seven lawsuits alleging a generic version of the digestion medication Reglan caused users to develop a serious neurological condition.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.